Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Article in English | IMSEAR | ID: sea-176926

ABSTRACT

The roots of Aristolochia argentina are used in folk medicine for the treatment of colitis, diarrhoea and hemorrhoids. In this study, based on ethnobotanical lead, we evaluated the antidiarrhoeal activity of Aristolochia argentina lyophilized aqueous extract (AALE) in rats and mice using various models. The castor oil and magnesium sulphate induced diarrhoea, the small intestinal transit in mice and the intestinal fluid accumulation were used in this study. At the doses of 62.5, 125 and 250 mg/kg p.o., the AALE showed significant antidiarrhoeal activity in both models. The AALE significantly reduced the intestinal fluid accumulation in the castor oil induced enteropooling. AALE delays small intestinal transit possibly, at least in part, involving opioid and α2-adrenergic receptors. The phytochemical analysis revealed the presence of carbohydrates, flavonoids, tannins, saponins and anthraquinones. The results suggest that AALE showed antidiarrhoeal activity by inhibiting intestinal motility and enteropooling property, justify its use in traditional medicine.

2.
Clinics ; 67(1): 61-67, 2012. ilus
Article in English | LILACS | ID: lil-610625

ABSTRACT

OBJECTIVE: Bevacizumab has been widely used as a vascular endothelial growth factor antagonist in the treatment of retinal vasoproliferative disorders in adults and, more recently, in infants with retinopathy of prematurity. Recently, it has been proposed that vascular endothelial growth factor acts as a protective factor for neurons and glial cells, particularly in developing nervous tissue. The purpose of this study was to investigate the effects of bevacizumab on the developing retinas of juvenile rabbits. METHODS: Juvenile rabbits received bevacizumab intravitreously in one eye; the other eye acted as an untreated control. Slit-lamp and fundoscopic examinations were performed both prior to and seven days after treatment. At the same time, retina samples were analyzed using immunohistochemistry to detect autophagy and apoptosis as well as proliferation and glial reactivity. Morphometric analyses were performed, and the data were analyzed using the Mann-Whitney U test. RESULTS: No clinical abnormalities were observed in either treated or untreated eyes. However, immunohistochemical analyses revealed a reduction in the occurrence of programmed cell death and increases in both proliferation and reactivity in the bevacizumab-treated group compared with the untreated group. CONCLUSIONS: Bevacizumab appears to alter programmed cell death patterns and promote gliosis in the developing retinas of rabbits; therefore, it should be used with caution in developing eyes.


Subject(s)
Animals , Male , Rabbits , Angiogenesis Inhibitors/adverse effects , Antibodies, Monoclonal, Humanized/adverse effects , Gliosis/pathology , Retina/drug effects , Retinal Ganglion Cells/drug effects , Cell Death/drug effects , Gliosis/chemically induced , Intravitreal Injections , Models, Animal , Random Allocation , Retina/growth & development , Retinal Ganglion Cells/pathology , Statistics, Nonparametric , Vascular Endothelial Growth Factor A/antagonists & inhibitors
3.
Braz. j. vet. res. anim. sci ; 46(5): 363-369, 2009. tab
Article in Portuguese | LILACS | ID: lil-538428

ABSTRACT

Para possível observação da hipertensão ocular com o uso de antiinflamatórios, foram selecionados 28 cães da raça Beagle. Para avaliação da pressão intra-ocular antes do tratamento, no dia 0 (zero) todos os animais tiveram a pressão intra-ocular avaliada às 08 horas e às 16 horas. No dia seguinte dez cães receberam meloxicam na dose de0,2 mg/kg, e 0,1mg/kg nos restantes quatro dias. Nove cães receberam prednisona na dose de 1,0 mg/kg durante cinco dias. Nove cães receberam somente porção de ração úmida. No quinto dia do tratamento todos os animais tiveram novamente a pressão intra-ocular avaliada às 08 horas e às 16 horas. Em todos os grupos, incluindo o grupo-controle, as maiores médias de pressão intra-ocular foram observadas no dia 5 (cinco). A diferença dos valores de pressão intra-ocular observada entre as medições das 08 horas e das 16 horas foi significativa, independente do tratamento e do dia considerado. O uso dos anti-inflamatórios esteroidal e não-esteroidal não foi capaz de causar hipertensão ocular e alguns fatores podem ser incriminados, como via de administração, dose e duração do tratamento utilizado, além da ausência de doença glaucomatosa nos cães selecionados


In order to observe a possible ocular hypertension associated with the use of anti-inflammatory drugs, 28 beagle dogs were selected. For evaluation of intraocular pressure before treatment, the totality of animals had their intraocular pressure measured at 8 a.m. and 4 p.m.on day 0 (zero). On the following day 10 animals received meloxican on dose of 0.2 mg/Kg and 0.1 mg/Kg on the four remaining days. Nine dogs received prednisone on dose of 1,0 mg/Kg during five days. Nine dogs received only wet feeding. On the fifth day of treatment the totality of dogs had their intraocular pressure measured at 8 a.m.and 4 p.m. For all groups, including control-group, the highest average values of intraocular pressure were observed on day 5 (five). The difference between the two evaluations of intra-ocular pressure (8a.m. and 4 p.m) was significant, independent of treatment and of the considered day. The use of both steroidal or non-steroidal antiinflammatory were not capable of causing ocular hypertension and some factors can be pointed out, such as route of administration, dosage and duration of therapy chosen, besides absence of glaucomatous disorder between the selected dogs


Subject(s)
Animals , Dogs , Anti-Inflammatory Agents , Ocular Hypertension/chemically induced , Intraocular Pressure , Prednisone/administration & dosage , Thiazines/administration & dosage , Thiazoles/administration & dosage , Administration, Oral , Anti-Inflammatory Agents, Non-Steroidal , Glaucoma/diagnosis , Thiazines/adverse effects , Thiazoles/adverse effects
4.
Cienc. Trab ; 6(12): 79-82, abr.-jun. 2004. ilus, tab
Article in Spanish | LILACS | ID: lil-385353

ABSTRACT

Ligaria Cuneifolia (R. et P.) Thiegh. (Loranthaceae) es una planta hemiparásita propia de Sudamérica. Es utilizada en Argentina primordialmente como antihipertensivo y antineoplásico. El presente trabajo fue llevado a cabo con el objeto de estudiar los metabolitos responsables de éstas y otras actividades atribuidas a esta entidad en la región centro-oeste de la Argentina. Para ello, se llevó a cabo la separación por cromatografía en columna y en capa fina, variando las fases estacionaria y móvil, purificando mendiante cristalizaciones y recristalizaciones sucesivas. La elucidación estructural se realizó por medio de Resonancia Magnética Nuclear (RMN)de 1H y de 13C y Espectrometría de Masas (EM). Como resultados fueron aislados por primera vez en esta especie dos compuestos mayoritarios que fueron caracterizados como triterpenos pentacíclicos del grupo lupeol: betulina y ácido betulínico.


Subject(s)
Hypertension/therapy , Loranthaceae , Neoplasms , Chromatography
SELECTION OF CITATIONS
SEARCH DETAIL